Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Vancomycin"" wg kryterium: Temat


Tytuł:
Epidemiology and infection control of vancomycin-resistant enterococci at a German university hospital: A three-year retrospective cohort study.
Autorzy:
Jochim-Vukosavic A; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Schwab F; Institute of Hygiene and Environmental Medicine, Charité-University Medicine, Berlin, Germany.
Knegendorf L; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Schlüter D; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Bange FC; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Ebadi E; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Baier C; Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 26; Vol. 19 (2), pp. e0297866. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Vancomycin-Resistant Enterococci*/genetics
Cross Infection*/epidemiology
Gram-Positive Bacterial Infections*/epidemiology
Enterococcus faecium*
Humans ; Hospitals, University ; Retrospective Studies ; Infection Control ; Anti-Bacterial Agents
Czasopismo naukowe
Tytuł:
Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance.
Autorzy:
Balkrishna A; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.; Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India.; Patanjali Yog Peeth (UK) Trust, Glasgow, United Kingdom.
Sharma S; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
Gohel V; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
Kumari A; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
Rawat M; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
Maity M; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
Sinha S; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
Dev R; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
Varshney A; Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.; Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India.; Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 08; Vol. 18 (11), pp. e0293605. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Vancomycin*
Drug-Related Side Effects and Adverse Reactions*/pathology
Rats ; Animals ; Humans ; Rats, Sprague-Dawley ; Creatinine ; Matrix Metalloproteinase 7/metabolism ; Lipocalin-2/metabolism ; Blood Urea Nitrogen ; Urea/metabolism ; Kidney/pathology ; RNA, Messenger/metabolism ; Biomarkers
Czasopismo naukowe
Tytuł:
Novel genomic islands and a new vanD-subtype in the first sporadic VanD-type vancomycin resistant enterococci in Norway.
Autorzy:
Al Rubaye MTS; Research Group for Host-Microbe Interactions, Department of Medical Biology, University of Tromsø (UiT) - The Arctic University of Norway, Tromsø, Norway.
Janice J; Research Group for Host-Microbe Interactions, Department of Medical Biology, University of Tromsø (UiT) - The Arctic University of Norway, Tromsø, Norway.; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North-Norway, Tromsø, Norway.
Bjørnholt JV; Department of Clinical Microbiology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Jakovljev A; Department of Medical Microbiology, St Olavs Hospital, Trondheim, Norway.
Hultström ME; Division of Nephrology, Department of Medicine, St Olavs Hospital, Trondheim, Norway.
Sundsfjord A; Research Group for Host-Microbe Interactions, Department of Medical Biology, University of Tromsø (UiT) - The Arctic University of Norway, Tromsø, Norway.; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North-Norway, Tromsø, Norway.
Hegstad K; Research Group for Host-Microbe Interactions, Department of Medical Biology, University of Tromsø (UiT) - The Arctic University of Norway, Tromsø, Norway.; Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North-Norway, Tromsø, Norway.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 23; Vol. 16 (7), pp. e0255187. Date of Electronic Publication: 2021 Jul 23 (Print Publication: 2021).
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genomic Islands*
Vancomycin Resistance*
Bacterial Proteins/*genetics
Enterococcus/*genetics
Enterococcus faecium/*genetics
Gram-Positive Bacterial Infections/*microbiology
Peptide Synthases/*genetics
Aged ; Anti-Bacterial Agents/pharmacology ; Enterococcus/drug effects ; Enterococcus/pathogenicity ; Enterococcus faecium/drug effects ; Enterococcus faecium/pathogenicity ; Female ; Gram-Positive Bacterial Infections/pathology ; Humans ; Middle Aged ; Vancomycin/pharmacology
SCR Organism:
Enterococcus casseliflavus
Czasopismo naukowe
Tytuł:
Vancomycin prescribing and therapeutic drug monitoring: Challenges of real clinical practice.
Autorzy:
Abdel Jalil MH; Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Ηijazeen R; Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Khaled Abu-Mahfouz F; Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Abu Hammour K; Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
Hasan Matalqah M; School of Pharmacy Jordan University of Science and Technology, Irbid, Jordan.
Saleh Khaleel Albadaineh J; School of Pharmacy Mu'tah University, Kerak, Jordan.
Khaled AlOmoush S; School of Pharmacy Jordan University of Science and Technology, Irbid, Jordan.
Al-Iede M; Department of Pediatrics, Jordan University Hospital, Amman, Jordan.; School of Medicine, The University of Jordan, Amman, Jordan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 May 17; Vol. 18 (5), pp. e0285717. Date of Electronic Publication: 2023 May 17 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Vancomycin*/therapeutic use
Physicians*
Humans ; Drug Monitoring ; Health Personnel ; Pharmacists ; Qualitative Research
Czasopismo naukowe
Tytuł:
Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.
Autorzy:
Adamu Y; Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Bayero University, Kano, Nigeria.
Puig-Asensio M; Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States of America.
Dabo B; College of Public Health, University of South Florida, Tampa, Florida, United States of America.
Schweizer ML; Department of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0293423. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article
MeSH Terms:
Daptomycin*/therapeutic use
Daptomycin*/pharmacology
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections*
Bacteremia*/drug therapy
Sepsis*/drug therapy
Adult ; Humans ; Vancomycin/adverse effects ; Treatment Outcome ; Retrospective Studies ; Anti-Bacterial Agents/pharmacology ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł:
Significant reduction of vancomycin resistant E. faecium in the Norwegian broiler population coincided with measures taken by the broiler industry to reduce antimicrobial resistant bacteria.
Autorzy:
Simm R; Institute of Oral Biology, University of Oslo, Oslo, Norway.
Slettemeås JS; Norwegian Veterinary Institute, Oslo, Norway.
Norström M; Norwegian Veterinary Institute, Oslo, Norway.
Dean KR; Norwegian Veterinary Institute, Oslo, Norway.
Kaldhusdal M; Norwegian Veterinary Institute, Oslo, Norway.
Urdahl AM; Norwegian Veterinary Institute, Oslo, Norway.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Dec 12; Vol. 14 (12), pp. e0226101. Date of Electronic Publication: 2019 Dec 12 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance, Multiple, Bacterial*
Enterococcus faecium*/isolation & purification
Vancomycin-Resistant Enterococci*/isolation & purification
Chickens/*microbiology
Food Industry/*organization & administration
Gram-Positive Bacterial Infections/*epidemiology
Infection Control/*organization & administration
Animals ; Anti-Bacterial Agents/pharmacology ; Antimicrobial Stewardship/organization & administration ; Antimicrobial Stewardship/standards ; Food Industry/standards ; Food Industry/trends ; Gram-Positive Bacterial Infections/microbiology ; Gram-Positive Bacterial Infections/prevention & control ; Gram-Positive Bacterial Infections/veterinary ; Infection Control/standards ; Infection Control/trends ; Microbial Sensitivity Tests ; Norway/epidemiology ; Poultry Diseases/epidemiology ; Poultry Diseases/microbiology ; Poultry Diseases/prevention & control ; Pyrans/pharmacology ; Vancomycin Resistance/physiology
Czasopismo naukowe
Tytuł:
Host-defense piscidin peptides as antibiotic adjuvants against Clostridioides difficile.
Autorzy:
Oludiran A; Department of Chemistry and Biochemistry, Old Dominion University, Norfolk, Virginia, United States of America.
Malik A; Department of Chemistry and Biochemistry, Old Dominion University, Norfolk, Virginia, United States of America.; Biomedical Sciences Program, Old Dominion University, Norfolk, Virginia, United States of America.
Zourou AC; Department of Applied Science, William & Mary, Williamsburg, Virginia, United States of America.
Wu Y; Irvine Department of Physics and Astronomy, University of California, Los Angeles, California, United States of America.
Gross SP; Ivrine Department of Developmental and Cell Biology, University of California, Los Angeles, California, United States of America.
Siryapon A; Irvine Department of Physics and Astronomy, University of California, Los Angeles, California, United States of America.
Poudel A; Department of Chemistry and Biochemistry, Old Dominion University, Norfolk, Virginia, United States of America.
Alleyne K; Department of Chemistry and Biochemistry, Old Dominion University, Norfolk, Virginia, United States of America.
Adams S; Department of Chemistry and Biochemistry, Old Dominion University, Norfolk, Virginia, United States of America.
Courson DS; Department of Chemistry and Biochemistry, Old Dominion University, Norfolk, Virginia, United States of America.
Cotten ML; Department of Applied Science, William & Mary, Williamsburg, Virginia, United States of America.
Purcell EB; Department of Chemistry and Biochemistry, Old Dominion University, Norfolk, Virginia, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 22; Vol. 19 (1), pp. e0295627. Date of Electronic Publication: 2024 Jan 22 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents*/pharmacology
Clostridioides difficile*
Antimicrobial Cationic Peptides/pharmacology ; Vancomycin/pharmacology ; Metronidazole ; Adjuvants, Immunologic ; Adjuvants, Pharmaceutic ; Clostridioides ; DNA
Czasopismo naukowe
Tytuł:
Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol.
Autorzy:
Hui KHM; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Lui CYG; Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Wu KLA; Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong East Cluster, Hospital Authority of Hong Kong, Hong Kong, China.
Chen J; Department of Pharmacy, Ruttonjee and Tang Shiu Kin Hospitals, Hong Kong East Cluster, Hospital Authority, Hong Kong, China.
Cheung YT; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Lam TNT; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 May 05; Vol. 17 (5), pp. e0267894. Date of Electronic Publication: 2022 May 05 (Print Publication: 2022).
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Methicillin-Resistant Staphylococcus aureus*
Vancomycin*
Adult ; Anti-Bacterial Agents ; Bayes Theorem ; Hong Kong ; Humans ; Internet ; Multicenter Studies as Topic ; Prospective Studies
Czasopismo naukowe
Tytuł:
Assessment of potential drug-related problems (PDRP) and clinical outcomes in bacterial meningitis patients admitted to tertiary care hospitals.
Autorzy:
Ali M; Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutics, University of Karachi, Karachi, Pakistan.; Niazi College of Pharmacy, Niazi Medical and Dental College, Sargodha, Pakistan.
Shoaib MH; Faculty of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutics, University of Karachi, Karachi, Pakistan.
Nesar S; Jinnah College of Pharmacy Sohail University, Karachi, Pakistan.
Akhtar H; Department of Pharmaceutics, Nazeer Hussain University Karachi, Karachi, Pakistan.
Shahnaz S; Department of Pharmacy Practice, Nazeer Hussain University Karachi, Karachi, Pakistan.
Khan Q; Sindh Government Dispensary, Gharibabad District Central, Karachi, Pakistan.
Imran J; NMC Specialty Hospital, Al Nahda, Dubai, UAE.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 09; Vol. 18 (10), pp. e0285171. Date of Electronic Publication: 2023 Oct 09 (Print Publication: 2023).
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Anti-Bacterial Agents*/adverse effects
Meningitis, Bacterial*/drug therapy
Adult ; Child ; Female ; Humans ; Male ; Cross-Sectional Studies ; Tertiary Care Centers ; Vancomycin/adverse effects ; Infant, Newborn ; Infant ; Child, Preschool ; Adolescent ; Young Adult ; Middle Aged ; Aged
Czasopismo naukowe
Tytuł:
Evaluation of the initial timing of infection control pharmacist-driven audit and monitoring of vancomycin therapy in patients with infectious diseases: A retrospective observational study.
Autorzy:
Sugita H; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.
Okada N; Department of Pharmacy, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.
Okamoto M; Division of Clinical Nutrition and Metabolism, Department of Clinical Pharmacy, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.
Abe M; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.
Sekido M; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, Japan.
Tanaka M; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.
Tamatukuri T; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, Showa University Hospital, Shinagawa-ku, Tokyo, Japan.
Naito Y; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, Showa University Hospital, Shinagawa-ku, Tokyo, Japan.
Yoshikawa M; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, Showa University Hospital, Shinagawa-ku, Tokyo, Japan.
Inoue E; Showa University Research Administration Center, Showa University, Shinagawa-ku, Tokyo, Japan.
Tanaka H; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Shinagawa-ku, Tokyo, Japan.; Department of Pharmacy, Showa University Hospital East Branch, Shinagawa-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 31; Vol. 18 (8), pp. e0291096. Date of Electronic Publication: 2023 Aug 31 (Print Publication: 2023).
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pharmacists*
Communicable Diseases*
Humans ; Middle Aged ; Aged ; Retrospective Studies ; Vancomycin/therapeutic use ; Hospitals, University ; Infection Control
Czasopismo naukowe
Tytuł:
Fibrinolytic and antibiotic treatment of prosthetic vascular graft infections in a novel rat model.
Autorzy:
Johansen MI; Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark.; Interdiciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark.
Rahbek SJ; Research Center for Emergency Medicine, Aarhus University Hospital, Aarhus N, Denmark.
Jensen-Fangel S; Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark.
Minero GAS; Interdiciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark.
Jensen LK; Faculty of Health and Medical Science, Department of Veterinary and Animal Sciences, University of Copenhagen, Copenhagen, Denmark.
Larsen OH; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.
Erikstrup LT; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus N, Denmark.
Seefeldt AM; Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark.
Østergaard L; Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark.
Meyer RL; Interdiciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark.; Department of Biology, Aarhus University, Aarhus C, Denmark.
Jørgensen NP; Department of Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jul 18; Vol. 18 (7), pp. e0287671. Date of Electronic Publication: 2023 Jul 18 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Methicillin-Resistant Staphylococcus aureus*
Prosthesis-Related Infections*/drug therapy
Prosthesis-Related Infections*/microbiology
Staphylococcal Infections*/drug therapy
Staphylococcal Infections*/microbiology
Animals ; Rats ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Tissue Plasminogen Activator/therapeutic use ; Vancomycin/pharmacology ; Vancomycin/therapeutic use
Czasopismo naukowe
Tytuł:
Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis.
Autorzy:
Jame W; Dept. of Pharmacology, University of Zawia, Alzawia, Libya.; Dept. of Clinical Pharmacy, Near East University, Lefkosa, Northern Cyprus.
Basgut B; Dept. of Clinical Pharmacy, Near East University, Lefkosa, Northern Cyprus.; Dept. of Pharmacology, Baskent University, Ankara, Turkey.
Abdi A; Dept. of Clinical Pharmacy, Near East University, Lefkosa, Northern Cyprus.; Dept. of Clinical Pharmacy, Yeditepe University, Istanbul, Turkey.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Nov 29; Vol. 16 (11), pp. e0260539. Date of Electronic Publication: 2021 Nov 29 (Print Publication: 2021).
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Anti-Bacterial Agents/*therapeutic use
Glycopeptides/*therapeutic use
Gram-Positive Bacterial Infections/*drug therapy
Vancomycin/*therapeutic use
Anti-Bacterial Agents/adverse effects ; Glycopeptides/adverse effects ; Gram-Positive Bacteria/drug effects ; Humans ; Methicillin-Resistant Staphylococcus aureus/drug effects ; Treatment Outcome ; Vancomycin/adverse effects
Czasopismo naukowe
Tytuł:
Vancomycin does not affect the enzymatic activities of purified VanSA.
Autorzy:
Upton EC; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
Maciunas LJ; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
Loll PJ; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jan 24; Vol. 14 (1), pp. e0210627. Date of Electronic Publication: 2019 Jan 24 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Bacterial Proteins/*isolation & purification
Bacterial Proteins/*metabolism
Histidine Kinase/*isolation & purification
Histidine Kinase/*metabolism
Vancomycin/*pharmacology
Models, Biological ; Mutant Proteins/metabolism ; Mutation/genetics ; Phosphorylation/drug effects ; Signal Transduction/drug effects ; Vancomycin Resistance
Czasopismo naukowe
Tytuł:
Evaluation of microbial and vancomycin treatments in ulcerative colitis in murine models.
Autorzy:
Hasan N; Department of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan, People's Republic of China.; Faculty of Health Science, Al-Baath University, Homs, Syria.
Yang H; Department of Microbiology, Northeast Forestry University, Harbin, Heilongjiang, People's Republic of China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 May 11; Vol. 18 (5), pp. e0285613. Date of Electronic Publication: 2023 May 11 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colitis, Ulcerative*/chemically induced
Colitis, Ulcerative*/drug therapy
Colitis*/chemically induced
Mice ; Animals ; Vancomycin/adverse effects ; Tumor Necrosis Factor-alpha/therapeutic use ; Disease Models, Animal ; RNA, Ribosomal, 16S ; Capsules/therapeutic use ; Dextran Sulfate/adverse effects ; Colon/microbiology
Czasopismo naukowe
Tytuł:
Vancomycin-resistant enterococci and coagulase-negative staphylococci prevalence among patients attending at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia.
Autorzy:
Ashagrie D; Diagnostic Medical Laboratory Unit, Felege-Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia.
Genet C; Department of Medical Laboratory Science, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
Abera B; Department of Medical Laboratory Science, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Apr 08; Vol. 16 (4), pp. e0249823. Date of Electronic Publication: 2021 Apr 08 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Staphylococcal Infections/*microbiology
Staphylococcus/*pathogenicity
Urinary Tract Infections/*microbiology
Vancomycin-Resistant Enterococci/*pathogenicity
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Coagulase/deficiency ; Coagulase/metabolism ; Drug Resistance, Multiple, Bacterial ; Ethiopia ; Female ; Humans ; Infant ; Male ; Middle Aged ; Outpatients/statistics & numerical data ; Prevalence ; Staphylococcal Infections/epidemiology ; Staphylococcus/enzymology ; Staphylococcus/isolation & purification ; Urinary Tract Infections/epidemiology ; Vancomycin-Resistant Enterococci/isolation & purification
Czasopismo naukowe
Tytuł:
Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
Autorzy:
Kohler P; Microbiology Department, Mount Sinai Hospital, Toronto, Ontario, Canada.; Clinic for Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Eshaghi A; Public Health Ontario, Public Health Ontario Laboratory, Toronto, Ontario, Canada.
Kim HC; Microbiology Department, Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Ontario, Canada.
Plevneshi A; Microbiology Department, Mount Sinai Hospital, Toronto, Ontario, Canada.
Green K; Microbiology Department, Mount Sinai Hospital, Toronto, Ontario, Canada.
Willey BM; Microbiology Department, Mount Sinai Hospital, Toronto, Ontario, Canada.
McGeer A; Microbiology Department, Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Ontario, Canada.
Patel SN; Public Health Ontario, Public Health Ontario Laboratory, Toronto, Ontario, Canada.; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Corporate Authors:
Toronto Invasive Bacterial Diseases Network (TIBDN)
Źródło:
PloS one [PLoS One] 2018 Mar 22; Vol. 13 (3), pp. e0193926. Date of Electronic Publication: 2018 Mar 22 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Bacterial Agents/*therapeutic use
Bacteremia/*microbiology
Enterococcus faecium/*drug effects
Enterococcus faecium/*genetics
Genetic Variation/*genetics
Vancomycin/*therapeutic use
Bacteremia/drug therapy ; Bacterial Proteins/genetics ; Genotype ; Gram-Positive Bacterial Infections/drug therapy ; Gram-Positive Bacterial Infections/epidemiology ; Gram-Positive Bacterial Infections/microbiology ; Humans ; Microbial Sensitivity Tests/methods ; Middle Aged ; Phenotype ; Prevalence ; Vancomycin Resistance/genetics
Czasopismo naukowe
Tytuł:
Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.
Autorzy:
Ferstl PG; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Filmann N; Institute of Biostatistics and Mathematical Modeling, Goethe University, Frankfurt am Main, Frankfurt, Germany.
Heilgenthal EM; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Schnitzbauer AA; Department of General and Visceral Surgery, University Hospital, Goethe University, Frankfurt am Main, Germany.
Bechstein WO; Department of General and Visceral Surgery, University Hospital, Goethe University, Frankfurt am Main, Germany.
Kempf VAJ; Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt am Main, Germany.; University Center for Infectious Diseases (UCI), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.; University Center of Competence for Infection Control of the State of Hesse, Frankfurt Main, Germany.
Villinger D; Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt am Main, Germany.; University Center for Infectious Diseases (UCI), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.; University Center of Competence for Infection Control of the State of Hesse, Frankfurt Main, Germany.
Schultze TG; Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt am Main, Germany.; University Center for Infectious Diseases (UCI), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.; University Center of Competence for Infection Control of the State of Hesse, Frankfurt Main, Germany.
Hogardt M; Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt am Main, Germany.; University Center for Infectious Diseases (UCI), University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.; University Center of Competence for Infection Control of the State of Hesse, Frankfurt Main, Germany.
Stephan C; Department for Internal Medicine II / Infectious Diseases, University Hospital, Goethe University, Frankfurt am Main, Germany.
Mutlak H; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University, Frankfurt am Main, Germany.
Weiler N; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Mücke MM; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Trebicka J; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Zeuzem S; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Waidmann O; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Welker MW; Department for Internal Medicine I / Gastroenterology and Hepatology, University Hospital, Goethe University, Frankfurt am Main, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jan 22; Vol. 16 (1), pp. e0245091. Date of Electronic Publication: 2021 Jan 22 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Carbapenems*
Drug Resistance, Multiple, Bacterial*
Gram-Negative Bacteria*
Gram-Negative Bacterial Infections*/mortality
Liver Cirrhosis*/mortality
Liver Cirrhosis*/surgery
Liver Transplantation*
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections*/etiology
Staphylococcal Infections*/mortality
Vancomycin-Resistant Enterococci*
beta-Lactam Resistance*
Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prevalence ; Prospective Studies ; Retrospective Studies ; Tertiary Care Centers
Czasopismo naukowe
Tytuł:
Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.
Autorzy:
Bakthavatchalam YD; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Babu P; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Munusamy E; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Dwarakanathan HT; Department of Orthopaedics, Christian Medical College, Vellore, India.
Rupali P; Infectious Diseases Training and Research Center (IDTRC), Christian Medical College, Vellore, India.
Zervos M; Infectious Diseases, Henry Ford Health System, Detroit, Michigan, United States of America.
John Victor P; Department of critical care unit, Christian Medical College, Vellore, India.
Veeraraghavan B; Department of Clinical Microbiology, Christian Medical College, Vellore, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Dec 30; Vol. 14 (12), pp. e0227009. Date of Electronic Publication: 2019 Dec 30 (Print Publication: 2019).
Typ publikacji:
Journal Article
MeSH Terms:
Anti-Bacterial Agents/*pharmacology
Methicillin-Resistant Staphylococcus aureus/*genetics
Staphylococcal Infections/*drug therapy
Teicoplanin/*therapeutic use
Vancomycin/*pharmacology
Vancomycin Resistance/*genetics
Anti-Bacterial Agents/therapeutic use ; Bacterial Proteins/genetics ; DNA Mutational Analysis ; DNA, Bacterial/genetics ; DNA, Bacterial/isolation & purification ; Down-Regulation ; Gene Expression Regulation, Bacterial/drug effects ; Humans ; India ; Methicillin-Resistant Staphylococcus aureus/drug effects ; Methicillin-Resistant Staphylococcus aureus/isolation & purification ; Microbial Sensitivity Tests ; Mutation/drug effects ; Operon/drug effects ; Operon/genetics ; Penicillin-Binding Proteins/genetics ; Real-Time Polymerase Chain Reaction ; Staphylococcal Infections/microbiology ; Teicoplanin/pharmacology ; Treatment Failure ; Up-Regulation ; Vancomycin/therapeutic use ; Vancomycin Resistance/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies